An Open-Label Extension Study to Evaluate the Long-term Safety and Efficacy of BMN 351 in Participants With Duchenne Muscular Dystrophy
Clinical trial NCT07573631 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT07573631
- Sponsor
- BioMarin Pharmaceutical
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-20
- Primary completion
- 2031-12-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.